Effect of a Synthetic Liver X Receptor Agonist TO901317 on Cholesterol Concentration in Goose Primary Hepatocytes

References

• AbildayevaK. Jansen P.J. Hirsch-ReinshagenV. Bloks V.W. Bakker A.H. Ramaekers F.C. de Vente J. Groen A.K. Wellington C.L. KuipersF. MulderM.,2006. 24(S)-hydroxycholesterol participates in a liver X receptor-controlled pathway in astrocytes that regulates apolipoprotein E-mediated cholesterol efflux. J. Biol. Chem. 281 :12799-12808.
   PubMed Web of Science ®Google Scholar
• AravindhanK. Webb C.L. JayeM. GhoshA. Willette R.N. Di Nardo N.J. Jucker B.M.,2006. Assessing the effects of LXR agonists on cellular cholesterol handling: a stable isotope tracer study. J. Lipid Res. 47 :1250-1260.
   PubMedGoogle Scholar
• ChenJ. ZacharekA. CuiX. ShehadahA. JiangH. RobertsC. LuM. ChoppM.,2009. Treatment of stroke with a synthetic liver X receptor agonist, TO901317, promotes synaptic plasticity and axonal regeneration in mice. J. Cerebr. Blood F. Met. 30 :102-109.
   PubMedGoogle Scholar
• DeBose-Boyd R.A. OuJ. Goldstein J.L. Brown M.S.,2001. Expression of sterol regulatory element-binding protein 1c (SREBP-1c) mRNA in rat hepatoma cells requires endogenous LXR ligands. P. Natl. Acad. Sci. USA 98 :1477-1482.
   PubMed Web of Science ®Google Scholar
• DüvelK. Yecies J.L. MenonS. RamanP. Lipovsky A.I. Souza A.L. TriantafellowE. MaQ. GorskiR. CleaverS. Vander Heiden M.G. Mac Keigan J.P. Finan P.M. Clish C.B. Murphy L.O. Manning B.D.,2010. Activation of a metabolic gene regulatory network downstream of mTOR complex 1. Mol. Cell 39 :171-183.
   PubMed Web of Science ®Google Scholar
• Emerling B.M. AkcakanatA.,2011. Targeting PI3K/mTOR signaling in cancer. Cancer Res. 71 :7351-7359.
   PubMedGoogle Scholar
• EngvallE. PerlmannP.,1972. Enzyme-linked immunosorbent assay, Elisa 3. Quantitation of specific antibodies by enzyme-labeled anti-immunoglobulin in antigen-coated tubes. J. Immunol. 109 :129-135.
   PubMed Web of Science ®Google Scholar
• Forman B.M. RuanB. ChenJ. Schroepfer G.J.Jr. Evans R.M.,1997. The orphan nuclear receptor LXRα is positively and negatively regulated by distinct products of mevalonate metabolism. P. Natl. Acad. Sci. USA 94 :10588-10593.
   PubMed Web of Science ®Google Scholar
• Goldstein J.L. DeBose-Boyd R.A. Brown M.S.,2006. Protein sensors for membrane sterols. Cell 124 :35-46.
   PubMed Web of Science ®Google Scholar
• GuoD. ReinitzF. YoussefM. HongC. NathansonD. AkhavanD. KugaD. Amzajerdi A.N. SotoH. ZhuS. BabicI. TanakaK. DangJ. IwanamiA. GiniB. DejesusJ. Lisiero D.D. Huang T.T. Prins R.M. Wen P.Y. Robins H.I. Prados M.D. Deangelis L.M. Mellinghoff I.K. Mehta M.P. James C.D. ChakravartiA. Cloughesy T.F. TontonozP. Mischel P.S.,2011. An LXR agonist promotes glioblastoma cell death through inhibition of an EGFR/AKT/SREBP-1/LDLR-dependent pathway. Cancer Discov. 1 :442-456.
   PubMed Web of Science ®Google Scholar
• Han C.C. WangJW. LiL. WangL. ZhangZ.,2009. The role of LXRα in goose primary hepatocyte lipogenesis. Mol. Cell. Biochem. 322 :37-42.
   PubMedGoogle Scholar
• Han C.C. Wang J.W. Xu H.Y. LiL. Ye J.Q. JiangL. Zhuo W.H.,2008. Effect of overfeeding on plasma parameters and mRNA expression of genes associated with hepatic lipogenesis in geese. Asian Austral. J. Anim. 21 :590-595.
   Google Scholar
• Horton J.D. Goldstein J.L. Brown M.S.,2002. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J. Clin. Invest. 109 :1125-1131.
   PubMed Web of Science ®Google Scholar
• Huwait E.A. Greenow K.R. Singh N.N. Ramji D.P.,2011. A novel role for c-Jun N-terminal kinase and phosphoinositide 3-kinase in the liver X receptor-mediated induction of macrophage gene expression. Cell. Signal. 23 :542-549.
   PubMedGoogle Scholar
• Janowski B.A. ShanB. Russell D.W.,2001. The hypocholesterolemic agent LY295427 reverses suppression of sterol regulatory element-binding protein processing mediated by oxysterols. J. Biol. Chem. 276 :45408-45416.
   PubMed Web of Science ®Google Scholar
• LaplanteM. Sabatini D.M.,2012. mTOR signaling in growth control and disease. Cell 149 :274-293.
   PubMed Web of Science ®Google Scholar
• LiS. OgawaW. EmiA. HayashiK. SengaY. NomuraK. HaraK. YuD. KasugaM.,2011. Role of S6K1 in regulation of SREBP1c expression in the liver. Biochem. Bioph. Res. Co. 412 :197-202.
   PubMedGoogle Scholar
• Peet D.J. Janowski B.A. Mangelsdorf D.J.,1998. The LXRs: a new class of oxysterol receptors. Curr. Opin. Genet. Dev. 8 :571-575.
   PubMed Web of Science ®Google Scholar
• PorstmannT. Santos C.R. GriffithsB. CullyM. WuM. LeeversS. Griffiths J.R. Chung Y.L. SchulzeA.,2008. SREBP activity is regulated by mTORC1 and contributes to Akt-dependent cell growth. Cell Metab. 8 :224-236.
   PubMed Web of Science ®Google Scholar
• Repa J.J. Mangelsdorf D.J.,2000. Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRalpha and LXRbeta. Gene. Dev. 14 :2819-2830.
   PubMed Web of Science ®Google Scholar
• Seglen P.O.,1976. Preparation of isolated rat liver cells. Method. Cell. Biol. 13 :29-83.
   PubMedGoogle Scholar
• ShimanoH. ShimomuraI. Hammer R.E. HerzJ. Goldstein J.L. Brown M.S. Horton J.D.,1997. Elevated levels of SREBP-2 and cholesterol synthesis in livers of mice homozygous for a targeted disruption of the SREBP-1 gene. J. Clin. Invest. 100 :2115-2124.
   PubMed Web of Science ®Google Scholar
• Sparrow C.P.,2002. A potent synthetic LXR agonist is more effective than cholesterol loading at inducing ABCA1 mRNA and stimulating cholesterol efflux. J. Biol. Chem. 277 :10021-10027.
   PubMed Web of Science ®Google Scholar
• TamehiroN. Shigemoto-MogamiY. KakeyaT. Okuhira K.I. SuzukiK. SatoR. NagaoT. Nishimaki-MogamiT.,2007. Sterol regulatory element-binding protein-2- and liver X receptor-driven dual promoter regulation of hepatic ABC transporter A1 gene expression: mechanism underlying the unique response to cellular cholesterol status. J. Biol. Chem. 282 :21090-21099.
   PubMed Web of Science ®Google Scholar
• TontonozP. Mangelsdorf D.J.,2003. Liver X receptor signaling pathways in cardiovascular disease. Mol. Endocrinol. 17 :985-993.
   PubMed Web of Science ®Google Scholar
• VenkateswaranA. Laffitte B.A. Joseph S.B. Mak P.A. Wilpitz D.C. Edwards P.A. TontonozP.,2000. Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXRalpha. P. Natl. Acad. Sci. USA 97 :12097-12102.
   PubMed Web of Science ®Google Scholar
• Wang B.T. Ducker G.S. Barczak A.J. BarbeanR. Erle D.J. Shokan K.M.,2011. The mammalian target of rapamycin regulates cholesterol biosynthetic gene expression and exhibits a rapamycin-resistant transcriptional profile. P. Natl. Acad. Sci. USA 108 :15201-15206.
   PubMed Web of Science ®Google Scholar
• WangN. RanallettaM. MatsuuraF.,2006. LXR-induced redistribution of ABCG1 to plasma membrane in macrophages enhances cholesterol mass efflux to HDL. Arterioscl. Throm. Vas. 26 :1310-1316.
   Google Scholar
• WangY. Rogers P.M. SuC. VargaG. Stayrook K.R. Burris T.P.,2008. Regulation of cholesterologenesis by the oxysterol receptor, LXRalpha. J. Biol. Chem. 283 :26332-26339.
   PubMed Web of Science ®Google Scholar
• WongJ. Quinn C.M. Brown A.J.,2006. SREBP-2 positively regulates transcription of the cholesterol efflux gene, ABCA1, by generating oxysterol ligands for LXR. Biochem. J. 400 :485-491.
   PubMedGoogle Scholar
• XuJ. DangY. Ren Y.R. Liu J.O.,2010. Cholesterol trafficking is required for mTOR activation in endothelial cells. P. Natl. Acad. Sci. USA 107 :4764-4769.
   PubMed Web of Science ®Google Scholar
• ZanottiI. PotiF. PedrelliM. FavariE. MoleriE. FranceschiniG. CalabresiL. BerniniF.,2008. The LXR agonist T0901317 promotes the reverse cholesterol transport from macrophages by increasing plasma efflux potential. J. Lipid Res. 49 :954-960.
   PubMed Web of Science ®Google Scholar
• ZhaoC. Dahlman-WrightK.,2009. Liver X receptor in cholesterol metabolism. J. Endocrinol. 204 :233-240.
   PubMedGoogle Scholar